Antibodies targeting IL-19 have prevented arthritis and osteolysis in animal models by diminishing the secretion of pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and RANKL [54]. Here, IL1B is linked to arthritic joint disease.